Effect of magnesium on fetal heart rate variability using computer analysis.
We studied 16 women, at 32 weeks' or more gestation who required magnesium sulfate (MgSO4) therapy for preterm labor or preeclampsia. A 60-minute Doppler fetal heart rate (FHR) tracing, analyzed by the Oxford Sonicaid System 8000, was obtained for 1 hour before and 2 hours after each patient received intravenous MgSO4 therapy. Maternal serum Mg2+ levels were obtained at the second monitoring session. Matched paired measures of FHR parameters were compared with the Student's t test. After MgSO4 administration, we noted significant falls in long-term variability, short-term variability, and total acceleration (more than 10 beats/min) counts. Reduced short-term and overall variability occurred in all cases with maternal serum Mg2+ levels more than 4.6 mg/dL. Therapeutic maternal serum Mg2+ levels are linked with decreases in long-term and short-term FHR variability and acceleration counts. These findings should be considered when evaluating resting FHR baseline of patients thus treated.
Hiett
A K
AK
Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta, USA.
Devoe
L D
LD
Brown
H L
HL
Watson
J
J
D000328:Adult; D001330:Electronic Data Processing; D005260:Female; D005323:Fetal Monitoring; D006340:Heart Rate, Fetal / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D008274:Magnesium / Q000097:blood / Q000494:pharmacology*; D008278:Magnesium Sulfate / Q000008:administration & dosage / Q000494:pharmacology; D007752:Obstetric Labor, Premature / Q000188:drug therapy; D011225:Pre-Eclampsia / Q000188:drug therapy; D011247:Pregnancy; D016216:Ultrasonography, Prenatal
D008278:Magnesium Sulfate; D008274:Magnesium